Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Appointments

Set Alert for Appointments

Former Immunocore Boss Forster Replaces Haurum At F-star Helm

As F-star starts its transition into a clinical stage company underpinned by two proprietary bispecific compounds due to enter clinic late 2019, Eliot Forster joins the company as CEO with plans to expand the company’s regulatory and clinical operations capabilities and raise new funds.

 

 

Appointments ImmunoOncology

Executives On The Move: Changes at the Top Ahead for Pfizer, New Division President at Bayer, and Advisors for VBI Vaccines.

A change will kick off 2019 for Pfizer when it promotes its COO to CEO. Bayer has a new president, pharmaceuticals, Americas, while VBI Vaccines announces the formation of three scientific and clinical advisory boards.

Appointments BioPharmaceutical

Cipla Rejigs Deck As Global Head Of Operations Moves On

Cipla’s global head (operations) Raju Subramanyam is leaving the firm to pursue his own ambitions. The exit has resulted in an interesting portfolio rejig at the Mumbai-based firm, known for its generally clear manufacturing compliance record.

Leadership Appointments

Executives On The Move: In the Commercial Arena, Shifting Positions at Mitsubishi, Tocagen, Shire and Vertex

This week we note shifts in the commercial arena. A new VP of sales and marketing at Mitsubishi Tanabe Pharma America and head of commercial at Tocagen. At the same time, a marketing lead departs Shire and the head of commercial, North America, exits Vertex Pharma.

Appointments BioPharmaceutical

Executives On The Move: Defectors From GSK, Pfizer, Shire, Dr Reddy's Get New Posts

Oxstem, ProMIS Neurosciences, resTORbio and Ultragenyx Pharmaceuticals are among firms recently announcing senior executive hires from the management ranks of big pharma. Meanwhile, Boehringer Ingelheim, Kane Biotech and Relypsa have all reported fresh resignations.

Appointments BioPharmaceutical

Executives On The Move: New CEOs Vaxil Bio and Akero Therapeutics, with Some Big Pharma Execs Joining Smaller Companies

This week’s appointments include a new chief business officer at Sutro Biopharma and a new chief medical officer at Crescendo Biologics. In addition, management from AstraZeneca and Gilead Biosciences take on the CEO role at smaller firms.

Appointments BioPharmaceutical

Executive All-Change: Bayer's Weinand To Join Sanofi, While Sanofi's Oelrich To Take His Place At Bayer

A head-spinning change of executives in Europe's leading pharmaceutical companies will see a new head of pharmaceuticals at Bayer and the former incumbent fetching up at Sanofi in the US.

 

Appointments Leadership

Executives On The Move: Promotions at Teva Pharmaceutical and Aileron Therapeutics

We report this week company promotions: at Teva Pharmaceutical Industries a new president of API and Biologics Operations, and at Aileron Therapeutics a new President and CEO. Also, we announce in new hires a chief commercial officer at Halozyme Therapeutics and a CEO at Rheos Medicines.

Appointments BioPharmaceutical

Executives On The Move: Management Changes at Bristol-Myers Squibb Company, Merck KGaA And Eli Lilly

This week’s appointments include a new chief commercial officer at Bristol-Myers Squibb, a global head of innovation medicine at Merck KGaA, and president at Lilly Oncology.

Appointments BioPharmaceutical

Executives On The Move: New Hires at Achillion And Bayer, And Promotions At Allegro Ophthalmics And Merz Pharma

This week’s new appointments include C-level promotions at Allegro Ophthalmics, Merz Pharma and Athenex. In addition, new directors joined the boards of Dicerna Pharmaceuticals and Spring Bank Pharmaceuticals.

Appointments BioPharmaceutical

Executives On The Move: New Hires At i2 Pharmaceuticals, Achillion, Hikma and Portola

Scrip’s new-look appointments feature brings you details of new hires and promotions within the pharma and biotech world from the past week. It includes a new CEO at i2 Pharmaceuticals and other senior appointments at Achillion Pharmaceuticals, Hikma Pharmaceuticals USA and Portola Pharmaceuticals. Click on the table heading tabs to see details of the industry’s latest company moves and promotions.

Appointments BioPharmaceutical

Appointments: Senior Hires At Allergan, Novartis, Array Biopharma, Zelluna Immunotherapy, Grail, Alzheon And Sigilon Therapeutics

Pfizer Oncology has lost its CMO to Allergan, while Novartis beefs up its ethical leadership, Array Biopharma appoints a new chair and Sigilon raids Bioverativ for its new CEO.

Appointments Commercial
See All
Advertisement
UsernamePublicRestriction

Register